Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study.

Poly(polyethylene glycol methyl ether methacrylate-co-methacrylic acid)-block-poly(methyl methacrylate) P(PEGMEMA-co-MAA)-b-PMMA block copolymer were prepared via RAFT (reversible addition-fragmentation chain transfer) polymerization and subsequently self-assembled into micelles as a drug delivery carrier for albendazole (ABZ). For comparison, the micelles were additionally cross-linked to study the effect of shell-cross-linking on the biological activity. The hydrodynamic diameter of cross-linked and un-cross-linked micelles was approximately 40 nm in both cases. While the cross-linked micelle was stable even in good solvents for both blocks, the un-cross-linked micelle was found to lose its integrity in cell growth media. Crosslinking had a major effect on the rate of drug release reducing it dramatically from 50% (uncrosslinked) to around 20% (crosslinked) over a 30 h incubation period. Both drug delivery systems were tested on human prostate cancer cells (PC-3, DU-145) and human ovarian cancer cells (OVCAR-3, A-2780). No toxic effects were measured with the unloaded micelle while the ABZ loaded un-cross-linked micelle lead to IC(50) values between 0.2 and 0.9 μM depending on the cell line. The IC(50) dropped to values between 0.006 and 0.06 μM, depending on cell line, once the micelles were stabilized by cross-linking. Three treatment cycles with ABZ for one day, followed by two days incubation in media using ABZ-loaded drug carriers led to complete cell death even at low concentrations in the case of the cross-linked micelle only. Cellular uptake has been studied using fluorescently labeled micelles and Nile red as model drug, showing cell uptake above the CMC but no micelle uptake below the CMC. Additional biological studies, such as colony formation assay and tubulin disorganization tests, were also performed to gain more insight into the effect of cross-linking of the shell of the micelle. In conclusion, shell-cross-linking is highly recommended, even for glassy micelles, for an efficient cellular uptake at low concentrations.

[1]  Shawn C. Owen,et al.  Stability of Self-Assembled Polymeric Micelles in Serum , 2011, Macromolecules.

[2]  Gaojian Chen,et al.  Thiol-yne and thiol-ene "click" chemistry as a tool for a variety of platinum drug delivery carriers, from statistical copolymers to crosslinked micelles. , 2011, Biomacromolecules.

[3]  Cornelus F. van Nostrum,et al.  Covalently cross-linked amphiphilic block copolymer micelles , 2011 .

[4]  D. Morris,et al.  An optimized RGD-decorated micellar drug delivery system for albendazole for the treatment of ovarian cancer: from RAFT polymer synthesis to cellular uptake. , 2011, Macromolecular bioscience.

[5]  C. Dumontet,et al.  Microtubule-binding agents: a dynamic field of cancer therapeutics , 2010, Nature Reviews Drug Discovery.

[6]  Lisa Wang,et al.  Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis. , 2010, Biochemical and biophysical research communications.

[7]  M. Poruchynsky,et al.  Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole , 2010, BMC Cancer.

[8]  M. Links,et al.  Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer , 2010, Cancer Chemotherapy and Pharmacology.

[9]  M. Yokoyama Polymeric micelles as a new drug carrier system and their required considerations for clinical trials , 2010, Expert opinion on drug delivery.

[10]  A. Shelton,et al.  Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study , 2010, BMC Cancer.

[11]  Kinam Park,et al.  Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.

[12]  S. Badar,et al.  Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. , 2009, Anticancer research.

[13]  M. Stenzel Hairy Core-Shell Nanoparticles via RAFT: Where are the Opportunities and Where are the Problems and Challenges? , 2009, Macromolecular rapid communications.

[14]  R. Zentel,et al.  The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells. , 2009, Biomaterials.

[15]  M. Links,et al.  Inhibition of Cell Proliferation, Vascular Endothelial Growth Factor and Tumor Growth by Albendazole , 2009, Cancer investigation.

[16]  Wenguang Liu,et al.  Degradable disulfide core-cross-linked micelles as a drug delivery system prepared from vinyl functionalized nucleosides via the RAFT process. , 2008, Biomacromolecules.

[17]  D. Morris,et al.  Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells. , 2008, Anticancer research.

[18]  Gaurav Sahay,et al.  Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. , 2008, Bioconjugate chemistry.

[19]  M. Stenzel RAFT polymerization: an avenue to functional polymeric micelles for drug delivery. , 2008, Chemical communications.

[20]  H. Rehage,et al.  A new pyrene-based fluorescent probe for the determination of critical micelle concentrations. , 2007, The journal of physical chemistry. B.

[21]  S. Armes,et al.  Recent advances in shell cross-linked micelles. , 2007, Chemical communications.

[22]  Thomas P. Davis,et al.  Complex Macromolecular Architectures by Reversible Addition Fragmentation Chain Transfer Chemistry: Theory and Practice , 2007 .

[23]  Kamalakanta Behera,et al.  Effect of added ionic liquid on aqueous Triton X-100 micelles. , 2007, Journal of colloid and interface science.

[24]  Craig J Hawker,et al.  Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. , 2006, Chemical Society reviews.

[25]  Lisa I. Wang,et al.  Albendazole: a Potent Inhibitor of Vascular Endothelial Growth Factor and Malignant Ascites Formation in OVCAR-3 Tumor-Bearing Nude Mice , 2006, Clinical Cancer Research.

[26]  D. Maysinger,et al.  Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[27]  S. P. Moulik,et al.  Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity. , 2006, Journal of colloid and interface science.

[28]  D. Maysinger,et al.  Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions , 2006, Journal of drug targeting.

[29]  G. Kwon,et al.  Amphiphilic block copolymer micelles for nanoscale drug delivery , 2006 .

[30]  A. Laschewsky,et al.  Synthesis of New Amphiphilic Diblock Copolymers and Their Self-Assembly in Aqueous Solution , 2005 .

[31]  Graeme Moad,et al.  Living radical polymerization by the RAFT process , 2005 .

[32]  Lisa I. Wang,et al.  Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis , 2005, Cancer Chemotherapy and Pharmacology.

[33]  K. Kataoka,et al.  NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel , 2005, British Journal of Cancer.

[34]  I. Orienti,et al.  Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[35]  N. Melik-Nubarov,et al.  Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. , 2005, Biochemistry.

[36]  H. Burt,et al.  Evidence for Modulation of P-glycoprotein-Mediated Efflux by Methoxypolyethylene Glycol-block-Polycaprolactone Amphiphilic Diblock Copolymers , 2004, Pharmaceutical Research.

[37]  C. Barner‐Kowollik,et al.  Amphiphilic block copolymers based on poly(2-acryloyloxyethyl phosphorylcholine) prepared via RAFT polymerisation as biocompatible nanocontainers. , 2004, Macromolecular bioscience.

[38]  G. Riess,et al.  Micellization of block copolymers , 2003 .

[39]  R. Liggins,et al.  Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  Muniruzzaman,et al.  Intracellular uptake of Pluronic copolymer: effects of the aggregation state , 2002 .

[41]  John Samuel,et al.  Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.

[42]  S. Armes,et al.  Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[43]  D. Morris,et al.  In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. , 2001, Cancer letters.

[44]  C. McCormick,et al.  Water-Soluble Polymers. 81. Direct Synthesis of Hydrophilic Styrenic-Based Homopolymers and Block Copolymers in Aqueous Solution via RAFT , 2001 .

[45]  Qi Zhang,et al.  Shell Cross-Linked Nanoparticles Containing Hydrolytically Degradable, Crystalline Core Domains , 2000 .

[46]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[47]  Alexander V. Kabanov,et al.  Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.

[48]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.

[49]  A. Eisenberg,et al.  Micellization in Block Polyelectrolyte Solutions. 2. Fluorescence Study of the Critical Micelle Concentration as a Function of Soluble Block Length and Salt Concentration , 1995 .

[50]  D. J. Lee Enthalpy-entropy compensation in ionic micelle formation , 1995 .

[51]  Markus Antonietti,et al.  Determination of the micelle architecture of polystyrene poly(4-vinylpyridine) block copolymers in dilute solution , 1994 .

[52]  C. Lipschultz,et al.  Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. , 1993, British Journal of Cancer.

[53]  S. Varshney,et al.  Critical micelle lengths for ionic blocks in solutions of polystyrene-b-poly(sodium acrylate) ionomers , 1992 .

[54]  E. Lacey,et al.  Interactions of benzimidazoles (BZ) with tubulin from BZ-sensitive and BZ-resistant isolates of Haemonchus contortus. , 1986, Molecular and biochemical parasitology.

[55]  R. C. Parish,et al.  Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms , 1976, Experientia.

[56]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[57]  Jean-François Gohy,et al.  Block copolymer micelles , 2005 .

[58]  Christine Allen,et al.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. , 2004, Journal of pharmaceutical sciences.